Third Harmonic Bio, Inc. THRD 深 滬
等待開盤 07-19 09:30:00 美东时间
5.455
+0.005
+0.09%
華盛通- 最 高5.48
- 今 開5.48
- 成交量 5.26万股
- 最 低 5.45
- 昨 收 5.45
- 總市值 2.46亿
- 52周最高 16.02
- 市盈率 靜 --
- 換手率 0.12%
- 52周最低 3.18
- 委 比 -82.84%
- 總股本 4512.78万
- 歷史最高 24.595
- 量 比 0.39
- 振 幅 0.55%
- 歷史最低 3.18
- 每 手 1
- 風險率 3.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Third Harmonic Bio Approves Liquidation and Dissolution Plan
The latest update is out from Third Harmonic Bio, Inc. ( ($THRD) ). Third Harmo...
06-12 20:29
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Third Harmonic Bio, Inc. announced that its stockholders overwhelmingly approved the Plan of Liquidation and Dissolution at the June 5, 2025 Annual Meeting. The initial distribution to stockholders is expected to be between $5.30 and $5.35 per share in the third quarter of 2025. Additionally, the company shared updated Phase 1 clinical data for THB335, showing an 85% reduction in serum tryptase with a favorable safety profile. The company has als...
06-12 12:00
Third Harmonic Bio Q1 EPS $(0.35) Misses $(0.29) Estimate
Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 75 percent decrease over losses of $(0.20) per share from
05-09 05:53
Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down
Third Harmonic Bio, Inc. ( ($THRD) ) has provided an announcement. On April 21,...
04-23 05:19
美股牛股 | 特朗普盯上海底金属资源！深海采矿公司TMC涨超45%
特朗普计划囤积深海金属资源，加拿大深海采矿公司TMC涨超45%；基因药物公司VERV涨超26%，基因疗法临床试验显示积极结果>>
04-15 19:10
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?
Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution.
04-14 23:07
Market-Moving News for April 14th
AAPL: 6% | Apple shares are trading higher after the Trump administration announced tariff exemptions for smartphones. THRD: 40% | Third Harmonic Bio shares are trading higher after the company announced a
04-14 19:24
美股大行评级 | 潜在涨幅686.94%！Sensei Biotherapeutics获Oppenheimer升目标价至4美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级，目标价从3.5美元升至4美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
Third Harmonic Bio Advances THB335 for Inflammatory Diseases
An update from Third Harmonic Bio, Inc. ( ($THRD) ) is now available. Third Har...
03-12 04:29
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
Sanofi and J&J halted a phase 3 E. coli vaccine trial due to insufficient efficacy. Sanofi's Q4 2024 IFRS EPS dropped by €0.15 following a $250M charge.
02-13 21:30
